Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) Overview

Save information for later
Sign Up

Learn About Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

What is the definition of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)?

Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is an uncommon form of epilepsy that runs in families. This disorder causes seizures that usually occur at night (nocturnally) while an affected person is sleeping. Some people with ADNFLE also have seizures during the day.

What are the causes of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)?

Mutations in the CHRNA2, CHRNA4, and CHRNB2 genes can cause ADNFLE. These genes provide instructions for making different parts (subunits) of a larger molecule called a neuronal nicotinic acetylcholine receptor (nAChR). This receptor plays an important role in chemical signaling between nerve cells (neurons) in the brain.

How prevalent is Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)?

ADNFLE appears to be an uncommon form of epilepsy; its prevalence is unknown. This condition has been reported in more than 100 families worldwide.

Is Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) an inherited disorder?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to raise the risk of developing epilepsy. About 70 percent of people who inherit a mutation in the CHRNA2, CHRNA4, or CHRNB2 gene will develop seizures. In most cases, an affected person has one affected parent and other relatives with the condition. Other cases are described as sporadic, which means an affected person has no family history of the disorder.

Who are the top Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) Local Doctors?
Advanced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
Advanced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Mercy Aco Clinical Services Inc

15740 S Outer 40 Rd, 
Chesterfield, MO 
 (1.3 mi)
Languages Spoken:
English, Arabic, French
Accepting New Patients
Offers Telehealth

Mohamed Tom is a Neurologist in Chesterfield, Missouri. Dr. Tom and is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). His top areas of expertise are Seizures, Memory Loss, Partial Seizure, and Photosensitive Epilepsy. Dr. Tom is currently accepting new patients.

Advanced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
Advanced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
222 S Woods Mill Rd, Suite 610n, 
Chesterfield, MO 
 (4.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

William Rosenfeld is a Neurologist in Chesterfield, Missouri. Dr. Rosenfeld and is rated as an Advanced provider by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). His top areas of expertise are Seizures, Photosensitive Epilepsy, Epilepsy, Partial Seizure, and Deep Brain Stimulation. Dr. Rosenfeld is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
Experienced in Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)

Todd B Silverman MD LLC

14825 N Outer 40 Rd, Suite 330 B, 
Chesterfield, MO 
 (0.3 mi)
Languages Spoken:
English
Accepting New Patients

Todd Silverman is a Neurologist in Chesterfield, Missouri. Dr. Silverman and is rated as an Experienced provider by MediFind in the treatment of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE). His top areas of expertise are Human Monocytic Ehrlichiosis, Headache, Memory Loss, and Parkinson's Disease. Dr. Silverman is currently accepting new patients.

What are the latest Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: April 01, 2009
Published By: National Institutes of Health